Alignment Healthcare Analyst Price Targets - Benzinga

Alignment Healthcare Inc

ALHCNASDAQ

Trade with Public

Trade with Public

$8.06

-0.37-4.39%

Ult. Agg.: Oct 23, 7:08 PM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Alignment Healthcare Analyst Price Targets - Benzinga

Alignment Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alignment Healthcare (ALHC).

Price Target Range — 13 Quarters

Analyst Consensus — 12 Analysts

10Buy

2Hold

Consensus RatingOverweight# Analysts12Avg. Consensus PT$17Upside to Avg. PT+111.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	UBS	Jonathan Yong	PT Cut	Neutral	$22→$9
Oct 12, 2026	TD Cowen	Ryan Langston	PT Cut	Buy	$21→$12
Oct 9, 2026	William Blair	Ryan Daniels	Downgrade	Outperform→Market Perform	—
Oct 9, 2026	JP Morgan	John Stansel	PT Cut	Overweight	$22→$10
Oct 9, 2026	Keybanc	Matthew Gillmor	PT Cut	Overweight	$28→$12
Oct 6, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$16→$10
Aug 4, 2026	JP Morgan	John Stansel	PT Cut	Overweight	$26→$22
Aug 3, 2026	Raymond James	John Ransom	Downgrade	Strong Buy→Outperform	$22→$19
May 26, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$19→$16
May 1, 2026	UBS	Jonathan Yong	PT Raise	Neutral	$21→$22
May 1, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$18→$19
Feb 5, 2026	JP Morgan	John Stansel	PT Raise	Overweight	$23→$26
Jan 16, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$19→$25
Jan 14, 2026	UBS	Kevin Caliendo	PT Raise	Neutral	$18→$21
Jan 6, 2026	Piper Sandler	Jessica Tassan	PT Raise	Overweight	$20→$30
Dec 17, 2025	JP Morgan	Lisa Gill	PT Raise	Overweight	$20→$23
Nov 24, 2025	JP Morgan	John Stansel	Upgrade	Neutral→Overweight	$18→$20
Nov 5, 2025	JP Morgan	Lisa Gill	PT Raise	Neutral	$17→$18
Nov 3, 2025	Barclays	Andrew Mok	PT Raise	Equal-Weight	$13→$18
Oct 31, 2025	UBS	Kevin Caliendo	PT Raise	Neutral	$17→$18

Analyst Ratings News

PRO
UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9

UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and lowers the price target from $22 to $9.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Alignment Healthcare, Lowers Price Target to $12

TD Cowen analyst Ryan Langston maintains Alignment Healthcare (NASDAQ:ALHC) with a Buy and lowers the price target from $21 to $12.

Benzinga Newsdesk

PRO
William Blair Downgrades Alignment Healthcare to Market Perform

William Blair analyst Ryan Daniels downgrades Alignment Healthcare (NASDAQ:ALHC) from Outperform to Market Perform.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $10

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $22 to $10.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on Alignment Healthcare, Lowers Price Target to $12

Keybanc analyst Matthew Gillmor maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $28 to $12.

Benzinga Newsdesk

Alignment Healthcare Stock Hit by Bearish Outlook After Costly Medicare Advantage Rating Downgrade

Alignment Healthcare faces potential stock pressure as its largest Medicare Advantage contract loses its crucial 4-star rating for 2027.

Vandana Singh